Liquidia Technologies Stock Today
| LQDA Stock | USD 9.10 0.05 0.55% |
Performance0 of 100
| Odds Of DistressLess than 43
|
Liquidia Technologies is trading at 9.10 as of the 8th of September 2024, a 0.55 percent increase since the beginning of the trading day. The stock's open price was 9.05. Liquidia Technologies has about a 43 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Liquidia Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of August 2024 and ending today, the 8th of September 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 26th of July 2018 | Category Healthcare | Classification Health Care |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. Liquidia Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 76.79 M outstanding shares of which 12.49 M shares are now shorted by private and institutional investors with about 12.2 trading days to cover. More on Liquidia Technologies
Moving against Liquidia Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Liquidia Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsLiquidia Technologies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Liquidia Technologies' financial leverage. It provides some insight into what part of Liquidia Technologies' total assets is financed by creditors.
| |||||
Liquidia Technologies (LQDA) is traded on NASDAQ Exchange in USA. It is located in 419 Davis Drive, Morrisville, NC, United States, 27560 and employs 145 people. Liquidia Technologies is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 698.44 M. Liquidia Technologies conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 76.79 M outstanding shares of which 12.49 M shares are now shorted by private and institutional investors with about 12.2 trading days to cover.
Liquidia Technologies currently holds about 98.32 M in cash with (41.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.52.
Check Liquidia Technologies Probability Of Bankruptcy
Ownership AllocationLiquidia Technologies maintains a total of 76.79 Million outstanding shares. Over half of Liquidia Technologies' outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Liquidia Ownership Details
Liquidia Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2024-03-31 | 685.4 K | |
| Boothbay Fund Management, Llc | 2024-03-31 | 558.7 K | |
| Bank Of America Corp | 2024-03-31 | 486.8 K | |
| Amvescap Plc. | 2024-03-31 | 459.4 K | |
| Northern Trust Corp | 2024-06-30 | 438.6 K | |
| Eversept Partners, Llc | 2024-06-30 | 373.6 K | |
| Tang Capital Management Llc | 2024-06-30 | 350 K | |
| Two Sigma Investments Llc | 2024-06-30 | 346.1 K | |
| Harbert Fund Advisors Inc | 2024-06-30 | 339.2 K | |
| Caligan Partners Lp | 2024-06-30 | 10.4 M | |
| Patient Square Capital | 2024-06-30 | 7.2 M |
Liquidia Technologies Historical Income Statement
Liquidia Stock Against Markets
Liquidia Technologies Corporate Management
| Jennifer Almond | Director Communications | Profile | |
| Robert Lippe | Chief Operations Officer | Profile | |
| Russell Schundler | General Secretary | Profile | |
| Rajeev MD | Chief Officer | Profile | |
| Ginger Denison | CoFounder | Profile | |
| Roger Jeffs | CEO Director | Profile | |
| Michael Hunter | Senior Operations | Profile |
Additional Information and Resources on Investing in Liquidia Stock
When determining whether Liquidia Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Liquidia Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Liquidia Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Liquidia Technologies Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Liquidia Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Liquidia Stock refer to our How to Trade Liquidia Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Liquidia Technologies. If investors know Liquidia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Liquidia Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.58) | Revenue Per Share 0.21 | Quarterly Revenue Growth (0.23) | Return On Assets (0.41) | Return On Equity (1.82) |
The market value of Liquidia Technologies is measured differently than its book value, which is the value of Liquidia that is recorded on the company's balance sheet. Investors also form their own opinion of Liquidia Technologies' value that differs from its market value or its book value, called intrinsic value, which is Liquidia Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Liquidia Technologies' market value can be influenced by many factors that don't directly affect Liquidia Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Liquidia Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Liquidia Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Liquidia Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.